Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 147 Breast Neoplasms 116 Prostatic Neoplasms 61 Multiple Myeloma 56 Neoplasms 55 Lung Neoplasms 49 Neoplasm Metastasis 44 Parkinson Disease 4, Autosomal Dominant Lewy Body 36 Ovarian Neoplasms 35 Colorectal Neoplasms 35 Leukemia, Lymphocytic, Chronic, B-Cell 32 Carcinoma, Renal Cell 27 Recurrence 26 Leukemia, Myeloid, Acute 26 Urinary Bladder Neoplasms 25 Carcinoma, Hepatocellular 24 Small Cell Lung Carcinoma 22 Myasthenia Gravis 22 Triple Negative Breast Neoplasms 21 Endometrial Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 20 Lymphoma, Large B-Cell, Diffuse 20 Nasopharyngeal Carcinoma 18 Melanoma 18 Lymphoma, Follicular 18 Stomach Neoplasms 17 Fallopian Tube Neoplasms 17 Non-Muscle Invasive Bladder Neoplasms 16 Brain Neoplasms 16 Pancreatic Neoplasms 15

Interventions

Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Optic Neuritis × 90 days × Clear all

NCT07100990 2026-05-05

TIMELY-PLEX

Mayo Clinic

Phase 3 Recruiting

Myelitis, Myelitis, Transverse, Optic Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡